04/02/25
Valereum Plc
("Valereum", "VLRM" or the "Company")
Exercise of Warrants
Valereum Plc (AQSE: VLRM) announces that it has received notice of exercise from a warrant holder for 577,367 Ordinary Shares at an exercise price of
Application will be made for the New Ordinary Shares, which will rank pari passu with the existing ordinary shares in issue, to be admitted to trading on the AQSE Growth Market ("Admission"). Dealings are expected to commence on or around 10 February 2025.
Total voting rights
Following the exercises of the warrant, the Company's total number of ordinary shares in issue will be 172,909,716. This figure may be used by shareholders as the denominator for the calculation to determine if they are required to notify the Company of their interest in, or a change to their interest in, the Company's securities pursuant to the Company's Articles
For further information, please contact:
|
Valereum Plc James Formolli, Chairman Engage with the company directly |
Tel: +44 7938 767319 |
|
Stanford Capital Partners Bob Pountney/ Patrick Claridge |
Tel: +44 023 3650 3650 |
|
AQSE Corporate Adviser First Sentinel Corporate Finance Brian Stockbridge / Gabrielle Cordeiro
|
Tel: +44 20 3855 5551 |
The Directors of the Company accept responsibility for the contents of this announcement.
For more information, please visit the Company's website at www.vlrm.com or to engage with the Valereum management team directly by asking questions, watching video summaries and seeing what other shareholders have to say. Navigate to our Interactive Investor hub here: SIGN UP
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
